Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PGBD5 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | GRM2 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | NGB | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | PHF2 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | GRM4 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
mRNA | SOS2 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | CDK19 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
mRNA | KCNH3 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | CDH24 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |